Efficacy of prolonged release melatonin in insomnia patients aged 55–80 years: quality of sleep and next-day alertness outcomes

References

• Dement WC, Miles LE, Carskadon MA. ‘White paper’ on sleep and aging. J Am Geriatr Soc 1982;30:25–50
   Google Scholar
• Buysse DJ, Reynolds CF, 3rd, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28: 193–213
   Google Scholar
• Hajak G. Epidemiology of severe insomnia and its consequences in Germany. Eur Arch Psychiatry Clin Neurosci 2001;251:49–56
   PubMed Web of Science ®Google Scholar
• Zeitlhofer J, Schmeiser-Rieder A, Tribl G, et al. Sleep and quality of life in the Austrian population. Acta Neurol Scand 2000;102:249–57
   PubMed Web of Science ®Google Scholar
• Riemann D, Voderholzer U, Berger M. Non-restorative sleep and insomnia. Diagnostic and therapeutic options for psychiatry and psychotherapy [in German]. Nervenarzt 2003;74:450–67; quiz 468–9
   Google Scholar
• Zammit GK, Weiner J, Damato N, et al. Quality of life in people with insomnia. Sleep 1999;22(Suppl 2):S379–85
   PubMed Web of Science ®Google Scholar
• Pilcher JJ, Ginter DR, Sadowsky B. Sleep quality versus sleep quantity: relationships between sleep and measures of health, well-being and sleepiness in college students. J Psychosom Res 1997;42:583–96
   Google Scholar
• Ohayon MM. Prevalence and correlates of nonrestorative sleep complaints. Arch Intern Med 2005;165:35–41
   PubMed Web of Science ®Google Scholar
• Krystal AD. Treating the health, quality of life, and functional impairments in insomnia. J Clin Sleep Med 2007;3:63–72
   PubMed Web of Science ®Google Scholar
• Morin CM. Measuring outcomes in randomized clinical trials of insomnia treatments. Sleep Med Rev 2003;7:263–79
   PubMed Web of Science ®Google Scholar
• Glass J, Lanctot KL, Herrmann N, et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 2005;331:1169
   PubMed Web of Science ®Google Scholar
• Landolt H, Gillin JC. GABA(A1A) receptors: involvement in sleep regulation and potential of selective agonists in the treatment of insomnia. CNS Drugs 2000;13:185–99
   Web of Science ®Google Scholar
• Brzezinski A. Melatonin in humans. N Engl J Med 1997;336:186–95
   PubMed Web of Science ®Google Scholar
• Nakagawa H, Sack RL, Lewy AJ. Sleep propensity free-runs with the temperature, melatonin and cortisol rhythms in a totally blind person. Sleep 1992;15:330–6
   Google Scholar
• Lockley SW, Skene DJ, Tabandeh H, et al. Relationship between napping and melatonin in the blind. J Biol Rhythms 1997;12:16–25
   PubMed Web of Science ®Google Scholar
• Cajochen C, Krauchi K, Wirz-Justice A. Role of melatonin in the regulation of human circadian rhythms and sleep. J Neuroendocrinol 2003;15:432–7
   Google Scholar
• Wyatt JK, Dijk DJ, Ritz-de Cecco A, et al. Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent. Sleep 2006;29:609–18
   Google Scholar
• Liu C, Weaver DR, Jin X, et al. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 1997;19:91–102
   PubMed Web of Science ®Google Scholar
• Shochat T, Luboshitzky R, Lavie P. Nocturnal melatonin onset is phase locked to the primary sleep gate. Am J Physiol 1997;273:R364–70
   Google Scholar
• Gorfine T, Assaf Y, Goshen-Gottstein Y, et al. Sleep-anticipating effects of melatonin in the human brain. Neuroimage 2006;31:410–8
   Google Scholar
• Gorfine T, Zisapel N. Melatonin and the human hippocampus, a time dependant interplay. J Pineal Res 2007;43:80–6
   PubMed Web of Science ®Google Scholar
• Sharma M, Palacios-Bois J, Schwartz G, et al. Circadian rhythms of melatonin and cortisol in aging. Biol Psychiatry 1989;25:305–19
   PubMed Web of Science ®Google Scholar
• Haimov I, Laudon M, Zisapel N, et al. Sleep disorders and melatonin rhythms in elderly people. BMJ 1994;309:167
   PubMed Web of Science ®Google Scholar
• Hajak G, Rodenbeck, A, Staedt J, et al. Nocturnal plasma melatonin levels in patients suffering from chronic primary insomnia. J Pineal Res 1996;19:116–122
   Web of Science ®Google Scholar
• Leger D, Laudon M, Zisapel N. Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy. Am J Med 2004;116: 91–5
   Google Scholar
• Buscemi N, Vandermeer B, Hooton N, et al. The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis. J Gen Intern Med 2005;20:1151–8
   PubMed Web of Science ®Google Scholar
• Parrott AC, Hindmarch I. The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations – a review. Psychopharmacology (Berl) 1980;71:173–9
   PubMed Web of Science ®Google Scholar
• Zisapel N, Laudon M. Subjective assessment of the effects of CNS-active drugs on sleep by the Leeds sleep evaluation questionnaire: a review. Hum Psychopharmacol 2003;18:1–20
   PubMed Web of Science ®Google Scholar
• Parrott AC, Hindmarch I. Factor analysis of a sleep evaluation questionnaire. Psychol Med 1978;8:325–9
   PubMed Web of Science ®Google Scholar
• Tarrasch R, Laudon M, Zisapel N. Cross-cultural validation of the Leeds sleep evaluation questionnaire (LSEQ) in insomnia patients. Hum Psychopharmacol 2003;18:603–10
   Google Scholar
• Rombaut N; Maillard F, Kelly FI. The quality of life of insomniacs questionnaire (QOLI). Med Sci Res 1990;18:845–7
   Google Scholar
• Kieser M, Rohmel J, Friede T. Power and sample size determination when assessing the clinical relevance of trial results by ‘responder analyses’. Stat Med 2004;23:3287–305
   Google Scholar
• Zisapel N, Nir T. Determination of the minimal clinically significant difference on a patient visual analog sleep quality scale. J Sleep Res 2003;12:291–8
   PubMed Web of Science ®Google Scholar
• Assocation WP. The management of insomnia, guidelines for clinical practice, 1991
   Google Scholar
• Chesson A Jr, Hartse K, Anderson WM, et al. Practice parameters for the evaluation of chronic insomnia. An American Academy of Sleep Medicine report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 2000;23:237–41
   Google Scholar
• Buysse DJ, Ancoli-Israel S, Edinger JD, et al. Recommendations for a standard research assessment of insomnia. Sleep 2006;29:1155–73
   PubMed Web of Science ®Google Scholar
• Backhaus J, Junghanns K, Broocks A, et al. Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. J Psychosom Res 2002;53:737–40
   PubMed Web of Science ®Google Scholar
• Guy W. ECDEU assessment manual for psychopharmacology (rev., 1976). Biometric Laboratory. The George Washington University, Kensington, Maryland, US, 1976
   Google Scholar
• Bech P, Olsen LR, Kjoller M, et al. Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being Scale. Int J Methods Psychiatr Res 2003;12:85–91
   PubMed Web of Science ®Google Scholar
• Ancoli-Israel S, Walsh JK, Mangano RM, et al. Zaleplon, A novel nonbenzodiazepine hypnotic, effectively treats insomnia in elderly patients without causing rebound effects. Prim Care Companion J Clin Psychiatry 1999;1:114–20
   Google Scholar
• Maquet P. Sleep function(s) and cerebral metabolism. Behav Brain Res 1995;69:75–83
   PubMed Web of Science ®Google Scholar
• Roth T, Seiden D, Sainati S, et al. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia. Sleep Med 2006;7:312–8
   PubMed Web of Science ®Google Scholar
• Otmani S, Staner C, Jacob N, et al. Effects of prolonged-release melatonin, zolpidem and their combination on psychomotor functions, memory recall and driving skills in healthy middle aged and elderly volunteers. J Sleep Medicine 2007 [submitted]
   Google Scholar